{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T10:40:18Z","timestamp":1783507218414,"version":"3.55.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11792-8","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:53:55Z","timestamp":1761044035000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical burden and biochemical profiles of viral hepatitis in a tertiary healthcare facility in North Central, Nigeria"],"prefix":"10.1186","volume":"25","author":[{"given":"Legbel Ikenna","family":"Uguru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4168-6104","authenticated-orcid":false,"given":"Adamu Ishaku","family":"Akyala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8207-9167","authenticated-orcid":false,"given":"Yakubu Boyi","family":"Ngwai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Ikenna","family":"Uguru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7473-7254","authenticated-orcid":false,"given":"Stephen Olaide","family":"Aremu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"key":"11792_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-024-20666-8","author":"JK Ademoyegun","year":"2024","unstructured":"Ademoyegun JK, Aremu SO. Socioeconomic determinants of malaria and hepatitis infections: insights from the federal medical center, Makurdi, North Central, Nigeria. BMC Public Health. 2024. https:\/\/doi.org\/10.1186\/s12889-024-20666-8.","journal-title":"BMC Public Health"},{"issue":"1","key":"11792_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s41043-025-00779-5","volume":"44","author":"DO Aremu","year":"2025","unstructured":"Aremu DO, Maxim A, Aremu SO, Aremu DE, Terhemen YD, Itodo SO, et al. The interplay of socio-demographic factors and disease prevalence: insights into malaria, hepatitis B, and hepatitis C in Lafia, Nasarawa State, Nigeria. J Health Popul Nutr. 2025;44(1):67. https:\/\/doi.org\/10.1186\/s41043-025-00779-5.","journal-title":"J Health Popul Nutr"},{"key":"11792_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s44337-025-00414-6","author":"JK Ademoyegun","year":"2025","unstructured":"Ademoyegun JK, Aremu SO. Co-occurence of hepatitis B, hepatitis C, and malaria in patients at bishop Murray medical Center, Makurdi, Benue State, Nigeria. Discov Med. 2025. https:\/\/doi.org\/10.1007\/s44337-025-00414-6.","journal-title":"Discov Med"},{"issue":"1","key":"11792_CR4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s41182-025-00712-w","volume":"53","author":"SO Aremu","year":"2025","unstructured":"Aremu SO, Adamu AI, Fatoke B, Uguru LI, Itodo SO, Aremu DO, et al. Challenges to implementing mandatory hepatitis B vaccination: bridging immunization gaps among health workers in sub-Saharan Africa. Trop Med Health. 2025;53(1):35. https:\/\/doi.org\/10.1186\/s41182-025-00712-w.","journal-title":"Trop Med Health"},{"issue":"5","key":"11792_CR5","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/jvh.13663","volume":"29","author":"N Veracruz","year":"2022","unstructured":"Veracruz N, Gish RG, Cheung R, Chitnis AS, Wong RJ. Global incidence and mortality of hepatitis B and hepatitis C acute infections, cirrhosis and hepatocellular carcinoma from 2010 to 2019. J Viral Hepat. 2022;29(5):352\u201365. https:\/\/doi.org\/10.1111\/jvh.13663.","journal-title":"J Viral Hepat"},{"issue":"1","key":"11792_CR6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41392-024-02072-z","volume":"10","author":"C Gan","year":"2025","unstructured":"Gan C, Yuan Y, Shen H, Gao J, Kong X, Che Z, et al. Liver diseases: epidemiology, causes, trends and predictions. Signal Transduct Target Ther. 2025;10:33. https:\/\/doi.org\/10.1038\/s41392-024-02072-z.","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"11792_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12030288","volume":"12","author":"SA Al-Busafi","year":"2024","unstructured":"Al-Busafi SA, Alwassief A. Global perspectives on the hepatitis B vaccination: challenges, achievements, and the road to elimination by 2030. Vaccines. 2024;12(3):288. https:\/\/doi.org\/10.3390\/vaccines12030288.","journal-title":"Vaccines"},{"key":"11792_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-024-20462-4","volume":"24","author":"J Li","year":"2024","unstructured":"Li J, Gao Z, Bai H, Wang W, Li Y, Lian J, et al. Global, regional, and national total burden related to hepatitis B in children and adolescents from 1990 to 2021. BMC Public Health. 2024;24:2936. https:\/\/doi.org\/10.1186\/s12889-024-20462-4.","journal-title":"BMC Public Health"},{"issue":"6","key":"11792_CR9","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.jhep.2015.02.044","volume":"62","author":"P Deltenre","year":"2015","unstructured":"Deltenre P. Studies on the epidemiology of hepatitis B and C virus infections are still needed. J Hepatol. 2015;62(6):1225\u20137.","journal-title":"J Hepatol"},{"issue":"2","key":"11792_CR10","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.gastha.2023.06.014","volume":"3","author":"K Roma","year":"2024","unstructured":"Roma K, Chandler TM, Dossaji Z, Patel A, Gupta K, Minacapelli CD, et al. A review of the systemic manifestations of hepatitis B virus infection, hepatitis D virus, hepatocellular carcinoma, and emerging therapies. Gastro Hep Advances. 2024;3(2):276\u201391. https:\/\/doi.org\/10.1016\/j.gastha.2023.06.014.","journal-title":"Gastro Hep Advances"},{"issue":"1","key":"11792_CR11","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3390\/healthcare13010043","volume":"13","author":"R Venkatesh","year":"2025","unstructured":"Venkatesh R, Huang AS, Gurmessa K, Hsu EB. Understanding barriers to hepatitis C antiviral treatment in low\u2013middle-income countries. Healthc (Basel). 2025;13(1):43. https:\/\/doi.org\/10.3390\/healthcare13010043.","journal-title":"Healthc (Basel)"},{"issue":"4","key":"11792_CR12","doi-asserted-by":"publisher","first-page":"371","DOI":"10.2217\/fvl.13.11","volume":"8","author":"M Lemoine","year":"2013","unstructured":"Lemoine M, Nayagam S, Thursz M. Viral hepatitis in resource-limited countries and access to antiviral therapies: current and future challenges. Future Virol. 2013;8(4):371\u201380. https:\/\/doi.org\/10.2217\/fvl.13.11.","journal-title":"Future Virol"},{"key":"11792_CR13","doi-asserted-by":"publisher","unstructured":"Stabinski L, O\u02bcConnor S, Barnhart M, Kahn RJ, Hamm TE. (2015). Prevalence of HIV and hepatitis B virus co-infection in sub-Saharan Africa and the potential impact and program feasibility of hepatitis B surface antigen screening in resource-limited settings. Journal of acquired immune deficiency syndromes. 1999;68 Suppl 3(Suppl 3):S274\u2013S285. https:\/\/doi.org\/10.1097\/QAI.0000000000000496","DOI":"10.1097\/QAI.0000000000000496"},{"issue":"5","key":"11792_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph20054142","volume":"20","author":"DB Fofana","year":"2023","unstructured":"Fofana DB, Somboro AM, Maiga M, Kampo MI, Diakit\u00e9 B, Cissoko Y, et al. Hepatitis B virus in West African children: systematic review and meta-analysis of HIV and other factors associated with hepatitis B infection. Int J Environ Res Public Health. 2023;20(5):4142. https:\/\/doi.org\/10.3390\/ijerph20054142.","journal-title":"Int J Environ Res Public Health"},{"key":"11792_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fgwh.2025.1508788","volume":"6","author":"N Mohammed","year":"2025","unstructured":"Mohammed N, Kassim J, Aliyi AA, Abdurebi MJ. Prevalence of viral hepatitis B and C infection and associated factors among pregnant women in Southeast Ethiopia: community-based cross-sectional study. Front Glob Womens Health. 2025;6:1508788. https:\/\/doi.org\/10.3389\/fgwh.2025.1508788.","journal-title":"Front Glob Womens Health"},{"issue":"2","key":"11792_CR16","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.cld.2012.03.006","volume":"16","author":"TH Lee","year":"2012","unstructured":"Lee TH, Kim WR, Poterucha JJ. Evaluation of elevated liver enzymes. Clin Liver Dis. 2012;16(2):183\u201398. https:\/\/doi.org\/10.1016\/j.cld.2012.03.006.","journal-title":"Clin Liver Dis"},{"key":"11792_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.curtheres.2024.100737","volume":"100","author":"S Thakur","year":"2024","unstructured":"Thakur S, Kumar V, Das R, Sharma V, Mehta DK. Biomarkers of hepatic toxicity: an overview. Curr Ther Res Clin Exp. 2024;100:100737. https:\/\/doi.org\/10.1016\/j.curtheres.2024.100737.","journal-title":"Curr Ther Res Clin Exp"},{"issue":"1","key":"11792_CR18","doi-asserted-by":"publisher","DOI":"10.4155\/fsoa-2017-0083","volume":"4","author":"KS Nallagangula","year":"2017","unstructured":"Nallagangula KS, Nagaraj SK, Venkataswamy L, Chandrappa M. Liver fibrosis: a compilation on the biomarkers status and their significance during disease progression. Future Sci OA. 2017;4(1):FSO250. https:\/\/doi.org\/10.4155\/fsoa-2017-0083.","journal-title":"Future Sci OA"},{"issue":"1","key":"11792_CR19","first-page":"3","volume":"28","author":"E Rossi","year":"2007","unstructured":"Rossi E, Adams LA, Bulsara M, Jeffrey GP. Assessing liver fibrosis with serum marker models. Clin Biochem Rev. 2007;28(1):3\u201310. PMID: 17603636; PMCID: PMC1904421.","journal-title":"Clin Biochem Rev"},{"issue":"6","key":"11792_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms12061213","volume":"12","author":"GN Lungu","year":"2024","unstructured":"Lungu GN, Diaconescu GI, Dumitrescu F, Docea AO, Mitrut R, Giubelan L, et al. Fibroscan\u00aeversus biochemical scores: a study of liver fibrosis in HIV with HBV co-infection. Microorganisms. 2024;12(6):1213. https:\/\/doi.org\/10.3390\/microorganisms12061213.","journal-title":"Microorganisms"},{"key":"11792_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","volume":"10","author":"SK Sarin","year":"2016","unstructured":"Sarin SK, Kumar M, Lau GK, Abbas Z, Chan HLY, Chen CJ, et al. Asian-pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int. 2016;10:1\u201398. https:\/\/doi.org\/10.1007\/s12072-015-9675-4.","journal-title":"Hepatol Int"},{"key":"11792_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12875-023-02157-8","volume":"24","author":"BO Olakunde","year":"2023","unstructured":"Olakunde BO, Adeyinka DA, Olakunde OA, Raji HB, Yahaya HB, Ijaodola OA, et al. Barriers to hepatitis B virus screening of pregnant women in primary healthcare centers in Nigeria: health workers\u2019 perspective. BMC Prim Care. 2023;24:209. https:\/\/doi.org\/10.1186\/s12875-023-02157-8.","journal-title":"BMC Prim Care"},{"key":"11792_CR23","doi-asserted-by":"publisher","first-page":"039","DOI":"10.23937\/2469-567X\/1510039","volume":"5","author":"SK Afari","year":"2018","unstructured":"Afari SK, Blay EA. Prevalence of haematological and serum biochemical abnormalities in HIV-infected patients in Ghana, before and after antiretroviral therapy. Int J Virol AIDS. 2018;5:039. https:\/\/doi.org\/10.23937\/2469-567X\/1510039.","journal-title":"Int J Virol AIDS"},{"issue":"12","key":"11792_CR24","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.4254\/wjh.v16.i12.1429","volume":"16","author":"SW Wang","year":"2024","unstructured":"Wang SW, Chang YW, Wang C, Cheng YM, Hsieh TH, Wang CC, et al. Clinical profiles and their interaction of concurrent metabolic associated steatotic liver disease and hepatitis B virus infection. World J Hepatol. 2024;16(12):1429\u201340. https:\/\/doi.org\/10.4254\/wjh.v16.i12.1429.","journal-title":"World J Hepatol"},{"issue":"4","key":"11792_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/medsci5040024","volume":"5","author":"OA Abulude","year":"2017","unstructured":"Abulude OA, Ahmed I, Sadisu FU. Assessment of hepatitis B viral infection as a predictor of hepatic enzymes and compounds alteration among antenatal patients. Med Sci. 2017;5(4):24. https:\/\/doi.org\/10.3390\/medsci5040024.","journal-title":"Med Sci"},{"issue":"1","key":"11792_CR26","doi-asserted-by":"publisher","DOI":"10.4103\/jrms.JRMS_846_17","volume":"26","author":"AF Elkhoudary","year":"2021","unstructured":"Elkhoudary AF, Elmougy R, Elsaid A, Wahba Y, Abdel-Aziz AF. Genetic and biochemical studies of hepatic carcinoma in the Egyptian population. J Res Med Sci. 2021;26(1):62. https:\/\/doi.org\/10.4103\/jrms.JRMS_846_17.","journal-title":"J Res Med Sci"},{"issue":"5","key":"11792_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/v14050856","volume":"14","author":"RMA Sampaio","year":"2022","unstructured":"Sampaio RMA, Dantas PEF, da Silva MIC, da Silva JR, Nunes PF, Gomes AC, et al. Comparison of patients monoinfected with hepatitis C virus and coinfected with hepatitis B\/C in the Amazon region of Brazil. Viruses. 2022;14(5):856. https:\/\/doi.org\/10.3390\/v14050856.","journal-title":"Viruses"},{"issue":"2","key":"11792_CR28","first-page":"869","volume":"77","author":"S Khan","year":"2022","unstructured":"Khan S, Alam M, Rauf Z, Noreen R, Shah K, Khan A, Ozdemir B, Selamoglu Z. Comparison of biochemical parameters in patients with hepatitis B, C, and dual hepatitis B and C in Northwest Pakistan. Arch Razi Inst. 2022;77(2):869\u201379. PMID: 36284958; PMCID: PMC9548253.","journal-title":"Arch Razi Inst"},{"issue":"9","key":"11792_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0139015","volume":"10","author":"G Yu","year":"2015","unstructured":"Yu G, Chi X, Wu R, Wu R, Wang X, Gao X, et al. Replication inhibition of hepatitis B virus and hepatitis C virus in co-infected patients in Chinese population. PLoS ONE. 2015;10(9):e0139015. https:\/\/doi.org\/10.1371\/journal.pone.0139015.","journal-title":"PLoS ONE"},{"issue":"4","key":"11792_CR30","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s00535-020-01665-z","volume":"55","author":"HW Lee","year":"2020","unstructured":"Lee HW, Chan HL. Unresolved issues of immune tolerance in chronic hepatitis B. J Gastroenterol. 2020;55(4):383\u20139. https:\/\/doi.org\/10.1007\/s00535-020-01665-z.","journal-title":"J Gastroenterol"},{"issue":"11","key":"11792_CR31","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.4254\/wjh.v13.i11.1688","volume":"13","author":"MA Kalas","year":"2021","unstructured":"Kalas MA, Chavez L, Leon M, Taweesedt PT, Surani S. Abnormal liver enzymes: a review for clinicians. World J Hepatol. 2021;13(11):1688\u201398. https:\/\/doi.org\/10.4254\/wjh.v13.i11.1688.","journal-title":"World J Hepatol"},{"issue":"5","key":"11792_CR32","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.jhep.2016.12.003","volume":"66","author":"J Wendon","year":"2017","unstructured":"Wendon J, Cordoba J, Dhawan A, Larsen FS, Manns M, Nevens F, et al. EASL clinical practical guidelines on the management of acute (fulminant) liver failure. J Hepatol. 2017;66(5):1047\u201381.","journal-title":"J Hepatol"},{"key":"11792_CR33","volume":"16","author":"AT Olayinka","year":"2016","unstructured":"Olayinka AT, Oyemakinde A, Balogun MS, Ajudua A, Nguku P, Aderinola M, et al. Seroprevalence of hepatitis B infection in Nigeria: a national survey. BMC Infect Dis. 2016;16:383.","journal-title":"BMC Infect Dis"},{"issue":"11","key":"11792_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/v16111723","volume":"16","author":"VA Adepoju","year":"2024","unstructured":"Adepoju VA, Udah DC, Adnani QES. Prevalence. Risk factors, and clinical profiles of hepatitis D virus in Nigeria: a systematic review, 2009\u20132024. Viruses. 2024;16(11):1723. https:\/\/doi.org\/10.3390\/v16111723.","journal-title":"Viruses"},{"issue":"2","key":"11792_CR35","doi-asserted-by":"publisher","first-page":"163","DOI":"10.4103\/1119-3077.151035","volume":"18","author":"BM Musa","year":"2015","unstructured":"Musa BM, Bussell S, Borodo MM, Samaila AA, Femi OL. Prevalence of hepatitis B virus infection in Nigeria, 2000\u20132013: a systematic review and meta-analysis. Niger J Clin Pract. 2015;18(2):163\u201372. https:\/\/doi.org\/10.4103\/1119-3077.151035.","journal-title":"Niger J Clin Pract"},{"key":"11792_CR36","unstructured":"World Health Organization. Global hepatitis report. WHO. 2017. ISBN: 978-92-4-156545-5. https:\/\/www.who.int\/publications\/i\/item\/9789241565455."},{"key":"11792_CR37","unstructured":"Lowe D, Sanvictores T, Zubair M et al. Alkaline Phosphatase. [Updated 2023 Oct 29]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK459201\/"},{"issue":"1","key":"11792_CR38","doi-asserted-by":"publisher","DOI":"10.5195\/cajgh.2019.313","volume":"8","author":"P Desikan","year":"2019","unstructured":"Desikan P, Rangnekar A, Khan Z, Panwalkar N, Bose P, Gulwani HV, et al. Sero-occurrence of HBV\/HCV co-infection and levels of liver enzymes among patients at a tertiary care hospital in central India: a pilot study. Cent Asian J Glob Health. 2019;8(1):313. https:\/\/doi.org\/10.5195\/cajgh.2019.313.","journal-title":"Cent Asian J Glob Health"},{"key":"11792_CR39","unstructured":"Grant LM, Purres M. Viral Hepatitis. [Updated 2024 Mar 10]. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK554549\/"},{"key":"11792_CR40","unstructured":"Girish V, Grant LM, John S, Hepatitis A. [Updated 2024 Oct 6]. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK459290\/"},{"key":"11792_CR41","doi-asserted-by":"publisher","unstructured":"European Association for the Study of the Liver. EASL Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2025;83(2):502\u201383. https:\/\/doi.org\/10.1016\/j.jhep.2025.03.018. Epub 10 May 2025. PMID: 40348683.","DOI":"10.1016\/j.jhep.2025.03.018"},{"issue":"10","key":"11792_CR42","doi-asserted-by":"publisher","first-page":"e01562","DOI":"10.1128\/JCM.01562-20","volume":"58","author":"S Kamili","year":"2020","unstructured":"Kamili S, Drobeniuc J, Araujo AC. Laboratory diagnostics for hepatitis. J Clin Microbiol. 2020;58(10):e01562\u201320. https:\/\/doi.org\/10.1128\/JCM.01562-20.","journal-title":"J Clin Microbiol"},{"issue":"10","key":"11792_CR43","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1097\/MEG.0000000000001651","volume":"32","author":"T Kantola","year":"2020","unstructured":"Kantola T, Koivisto H, Hockerstedt K. Liver enzyme abnormalities in hepatitis patients. Eur J Gastroenterol Hepatol. 2020;32(10):1321\u20136. https:\/\/doi.org\/10.1097\/MEG.0000000000001651.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"2","key":"11792_CR44","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00046-19","volume":"33","author":"MH Nguyen","year":"2020","unstructured":"Nguyen MH, Wong G, Gane E, Kao JH, Dusheiko G. Hepatitis B virus: advances in prevention, diagnosis, and therapy. Clin Microbiol Rev. 2020;33(2):e00046\u201319. https:\/\/doi.org\/10.1128\/CMR.00046-19.","journal-title":"Clin Microbiol Rev"},{"key":"11792_CR45","doi-asserted-by":"publisher","DOI":"10.1177\/23259582241292511","volume":"23","author":"E Odeghe","year":"2024","unstructured":"Odeghe E, Oyeleke G, Odofin M, Duguru M, Davwar P, Nyam D, et al. Hepatitis B and C virus co-infection and their association with liver disease in persons with HIV in Nigeria. Journal of the International Association of Providers of AIDS Care (JIAPAC). 2024;23:23259582241292511. https:\/\/doi.org\/10.1177\/23259582241292511.","journal-title":"Journal of the International Association of Providers of AIDS Care (JIAPAC)"},{"issue":"12","key":"11792_CR46","doi-asserted-by":"publisher","first-page":"e49920","DOI":"10.7759\/cureus.49920","volume":"15","author":"H Wazir","year":"2023","unstructured":"Wazir H, Abid M, Essani B, Saeed H, Ahmad Khan M, Nasrullah F, Qadeer U, Khalid A, Varrassi G, Muzammil MA, Maryam A, Syed ARS, Shah AA, Kinger S, Ullah F. Diagnosis and treatment of liver disease: current trends and future directions. Cureus. 2023;15(12):e49920. https:\/\/doi.org\/10.7759\/cureus.49920.","journal-title":"Cureus"},{"issue":"10","key":"11792_CR47","first-page":"1452","volume":"26","author":"YZ Yin","year":"2006","unstructured":"Yin YZ, Chen XW, Li XM, Hou HY, Shi ZJ. [Intrauterine HBV infection: risk factors and impact of HBV DNA]. Nan Fang Yi Ke Da Xue Xue Bao. 2006;26(10):1452\u20134. Chinese. PMID: 17062350.","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"issue":"4","key":"11792_CR48","doi-asserted-by":"publisher","first-page":"344","DOI":"10.2478\/jtim-2024-0015","volume":"12","author":"J Wu","year":"2024","unstructured":"Wu J, Wang H, Xiang Z, Jiang C, Xu Y, Zhai G, et al. Role of viral hepatitis in pregnancy and its triggering mechanism. J Transl Intern Med. 2024;12(4):344\u201354. https:\/\/doi.org\/10.2478\/jtim-2024-0015.","journal-title":"J Transl Intern Med"},{"issue":"3","key":"11792_CR49","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1515\/mr-2024-0022","volume":"4","author":"SA Hudu","year":"2024","unstructured":"Hudu SA, Shinkafi SH, Jimoh AO. A critical review of diagnostic and prognostic markers of chronic hepatitis B infection. Med Rev. 2024;4(3):225\u201334. https:\/\/doi.org\/10.1515\/mr-2024-0022.","journal-title":"Med Rev"},{"issue":"10","key":"11792_CR50","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1007\/s10096-012-1613-y","volume":"31","author":"Y Yang","year":"2012","unstructured":"Yang Y, Deng L, Li X, Shi Z, Chen D, Chen X, et al. Evaluation of the prognosis of fulminant viral hepatitis in late pregnancy by the MELD scoring system. Eur J Clin Microbiol Infect Dis. 2012;31(10):2673\u20138. https:\/\/doi.org\/10.1007\/s10096-012-1613-y.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"11792_CR51","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2478\/jtim-2023-0010","volume":"11","author":"HJ Fu","year":"2023","unstructured":"Fu HJ, Zhou M, Huang ZH, Chen YX, Wu XX. Severe acute hepatitis of unknown origin in children: clinical issues of concern. J Transl Intern Med. 2023;11(1):19\u201323. https:\/\/doi.org\/10.2478\/jtim-2023-0010.","journal-title":"J Transl Intern Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11792-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11792-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11792-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:05:06Z","timestamp":1761087906000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11792-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11792"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11792-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7130610\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"assertion":[{"value":"15 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki (2013 version) as adopted by the World Medical Association. Ethical approval for the study was obtained from the Health Research Ethics Committee of the Federal Medical Center, Keffi (FMC, Keffi), a fully registered committee under the National Health Research Ethics Committee (NHREC), FMH-Ref No: C.5187\/76IT. Approval was granted after a defense of the research proposal during the Committee\u2019s ethical screening interview held on 14th November 2024. As this was a retrospective chart review, the requirement for obtaining informed consent from participants was waived by the Health Research Ethics Committee of FMC, Keffi, in accordance with national research ethics regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for participation"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1368"}}